Stay updated on CARPALL: CAR T-cells for CD19+ Malignancies Clinical Trial
Sign up to get notified when there's something new on the CARPALL: CAR T-cells for CD19+ Malignancies Clinical Trial page.

Latest updates to the CARPALL: CAR T-cells for CD19+ Malignancies Clinical Trial page
- Check6 days agoChange DetectedA new revision entry 'Revision: v3.3.3' was added to the Record History, and the 'HHS Vulnerability Disclosure' footer link plus the previous revision 'Revision: v3.3.2' were removed.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check35 days agoChange DetectedA new revision entry v3.3.2 was added to the history and the previous revision v3.2.0 was removed.SummaryDifference0.1%

- Check42 days agoChange DetectedRemoved the government funding/operational status notice at the top of the page; core study data and navigation remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check56 days agoChange DetectedThe history page appears the same overall, with updated Last Update Posted dates and version entries. No study details or outcomes have changed.SummaryDifference0.1%

- Check84 days agoChange DetectedThe page now communicates an updated operating-status notice and a new software version (v3.2.0), replacing the previous version tag (v3.1.0).SummaryDifference12%

- Check92 days agoChange DetectedPage version updated from v3.0.2 to v3.1.0; no other substantive content changes detected.SummaryDifference0.3%

Stay in the know with updates to CARPALL: CAR T-cells for CD19+ Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CARPALL: CAR T-cells for CD19+ Malignancies Clinical Trial page.